USAID-India End TB Alliance to eliminate TB announced

Published On 2018-09-29 03:30 GMT   |   Update On 2018-09-29 03:30 GMT
Advertisement

The US and India have formed an alliance comprising leading experts in public and private sectors to combat the menace of tuberculosis, an American official said.


US Agency for International Development (USAID) administrator Mark Green announced the formation of 'USAID-India End TB Alliance' at an event in New York in presence of Union Health Minister J P Nadda.




Advertisement


Two alliance members - Dr. Soumya Swaminathan, Director General of the World Health Organisation, and Blessina Kumar from the Global Coalition of TB Activists - were present during the announcement.


India accounts for 27 per cent of the world's TB cases, with 421,000 deaths per year, Green said.


That's one person dying every minute, he added. Referring to his visit to India in November, he said he met with a group of TB survivors and their families and learnt about the barriers to testing and treatment they face.


"I was especially moved by those who were initially deterred from seeking treatment because of stigma but persevered, and now those same people, mostly women, are working as patient advocates, supporting others who are also struggling with stigma," Green said.


"A major reason for hope in India is that Prime Minister (Narendra) Modi has made an ambitious, but determined commitment to achieve a TB-free India by 2025," he said.


USAID is making an initial USD 30 million commitment, subject to the approval of the US Congress, Green said.


Read Also: Nadda addresses High-Level Meeting on Tuberculosis at 73rd session of UNGA

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News